Department of Neurosurgery, Charité Universitätsmedizin Berlin, Berlin, Germany.
Neurosurgery. 2012 Jan;70(1):49-54; discussion 54-5. doi: 10.1227/NEU.0b013e31822cb979.
The excimer laser-assisted nonocclusive anastomosis (ELANA) technique enables large-caliber bypass revascularization without temporary occlusion of the parent artery.
To present the surgical experience of 2 bypass centers using ELANA in the treatment of complex intracranial lesions.
Between July 2002 and December 2007, 64 consecutive patients (37 in Germany and 27 in Finland) were selected for high-flow bypass surgery with ELANA. Modified Rankin Scale, a bypass success rate, and the success rate of the laser arteriotomy were assessed.
In 66 surgeries for 64 intent-to-treat patients, 58 ELANA procedures were completed successfully. A favorable outcome (postoperative modified Rankin Scale score less than or equal to preoperative modified Rankin Scale) at 3 months was achieved in 43 of 56 patients (77%) with anterior circulation lesions (37 of the 43 patients had aneurysms, 4 had ischemia, and 2 received a bypass before tumor removal) and only in 2 of 8 patients (25%) with posterior circulation aneurysms. Perioperative (< 7 days) mortality for anterior and posterior circulation aneurysms was 6% and 50%, respectively. At the 3-month follow-up, 12% and 63% of patients with anterior and posterior circulation aneurysms, respectively, were dead. The success rate of the laser arteriotomy was 70%. Another 14% were retrieved manually after a nearly complete laser arteriotomy.
The ELANA procedure requires a meticulous and careful operative technique. Morbidity and especially mortality rates, usually unrelated to ELANA, are comparable to those of contemporary series of conventional high-flow revascularization operations. This underscores the overall complexity of treating neurovascular pathologies by high-flow bypasses.
准分子激光辅助非闭塞吻合术(ELANA)技术可在不临时阻断母动脉的情况下实现大口径旁路血运重建。
介绍 2 个旁路中心使用 ELANA 治疗复杂颅内病变的手术经验。
2002 年 7 月至 2007 年 12 月,共有 64 例患者(德国 37 例,芬兰 27 例)被选择行 ELANA 高流量旁路手术。采用改良 Rankin 量表评估旁路成功率和激光血管切开术的成功率。
在 66 例 64 例意向治疗患者的手术中,成功完成了 58 例 ELANA 手术。在有前循环病变的 56 例患者中(其中 37 例患者有动脉瘤,4 例患者有缺血,2 例患者在肿瘤切除前接受旁路手术),43 例患者中有 43 例(77%)术后 3 个月时预后良好(改良 Rankin 量表评分术后等于或小于术前),而后循环动脉瘤患者中仅 2 例(25%)预后良好。前循环和后循环动脉瘤的围手术期(<7 天)死亡率分别为 6%和 50%。在术后 3 个月的随访中,前循环和后循环动脉瘤患者的死亡率分别为 12%和 63%。激光血管切开术的成功率为 70%。另外 14%的患者在几乎完全激光血管切开后需要手动取回。
ELANA 手术需要细致和小心的手术技术。发病率,特别是死亡率通常与 ELANA 无关,与当代传统高流量血运重建手术的发病率相当。这突出表明通过高流量旁路治疗神经血管病变的整体复杂性。